Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-04

Clinical Trial Update: Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma [NA]

View source ↗

Summary

The trial evaluating when to initiate anticoagulation in patients with atrial fibrillation after acute or chronic subdural hematoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Subdural Hematoma, Atrial Fibrillation | NA | Status: TERMINATED